Immunity of Certain Persons. No recourse under or upon any obligation, covenant or agreement contained in this Indenture, or in any Subordinated Note, or because of any indebtedness evidenced thereby, will be had against any past, present or future shareholder, employee, officer or director, as such, of the Company or Trustee or of any predecessor or successor, either directly or through the Company or Trustee or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Subordinated Notes by the Holders and as part of the consideration for the issue of the Subordinated Notes.
Immunity of Certain Persons. Section 13.01.
Immunity of Certain Persons. No recourse under or upon any obligation, covenant or agreement contained in this Indenture, or in any Subordinated Note, or because of any indebtedness evidenced thereby, will be had against any past, present or future shareholder, employee, officer or director, as such, of the Company or of any predecessor or successor, either directly or through the Company or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Subordinated Notes by the Holders and as part of the consideration for the issue of the Subordinated Notes. Section 116 Waiver of Jury Trial. EACH PARTY HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS INDENTURE, THE SUBORDINATED NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
Immunity of Certain Persons. No recourse for the payment of the principal of or premium, if any, or interest on any Subordinated Note, or for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement contained in the Indenture or in any Subordinated Note, or for any claim based thereon or otherwise in respect thereof, will be had against any past, present or future incorporator, shareholder, employee, officer, director or agent, as such, of the Company or of any predecessor or successor, either directly or through the Company or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, it being expressly understood that this Indenture and the obligations hereunder are solely corporate obligations, and that no such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, employees, officers, directors or agents, as such, of the Company or of any predecessor or successor, or any of them, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Subordinated Notes or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, shareholder, employee, officer, director or agent, as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Subordinated Notes or implied therefrom, are hereby expressly waived and released by the acceptance of the Subordinated Notes by the Holders and as part of the consideration for the execution of this Indenture and the issuance of the Subordinated Notes.
Immunity of Certain Persons. No recourse under or upon any obligation, covenant or agreement contained in this Indenture, or in any Debt Security, or because of any indebtedness evidenced thereby, will be had against any past, present or future shareholder, employee, officer or director, as such, of the Company or of any predecessor or successor, either directly or through the Company or any predecessor or successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Debt Securities by the Holders thereof and as part of the consideration for the issuance of the Debt Securities.
Immunity of Certain Persons. No recourse for the payment of the principal of or premium, if any, or interest on any Note, or for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company, contained in this Indenture or in any supplemental indenture, or in any Note, or because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of the Notes.
Immunity of Certain Persons. 16 Section 1.16 Waiver of Jury Trial. 16 Section 1.17 Force Majeure. 17 Section 1.18 USA PATRIOT Act. 17 Section 1.19 No Sinking Fund. 17 Section 1.20 Rules of Construction. 17 ARTICLE II THE SUBORDINATED NOTES 18 Section 2.01 Forms Generally. 18 Section 2.02 Definitive Subordinated Notes. 18 Section 2.03 Global Subordinated Notes. 18 Section 2.04 Restricted Subordinated Notes. 18 Section 2.05 Execution and Authentication. 19 Section 2.06 Registrar and Paying Agent. 20 Section 2.07 Registration of Transfer and Exchange. 20 Section 2.08 Exchange Offer. 23 Section 2.09 Mutilated, Destroyed, Lost and Stolen Subordinated Notes. 24 Section 2.10 Payment of Interest; Rights to Interest Preserved. 25 Section 2.11 Persons Deemed Owners. 26 Section 2.12 Cancellation. 26 Section 2.13 Computation of Interest. 26 Section 2.14 CUSIP Numbers. 28
Immunity of Certain Persons. No recourse for the payment of the Payments on any Note, if any are due and payable pursuant to and in accordance with the terms of the Notes and this Indenture, or for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company, contained in this Indenture or in any supplemental indenture, or in any Note, or because of the creation of any contingent indebtedness represented thereby, shall be had against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of the Notes.
Immunity of Certain Persons. No recourse for the payment of the principal of or interest on any Note, or for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company, contained in this Indenture or in any supplemental indenture, or in any Note, or because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or any successor corporation, either directly or through the Company or any successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of the Notes.
Immunity of Certain Persons. Section 13.01 No Personal Liability of Directors, Officers, Employees and Stockholders 88 ARTICLE XIV AMENDMENTS, SUPPLEMENTS AND WAIVERS Section 14.01 Without Consent of Holders 88 Section 14.02 With Consent of Holders; Limitations 89 Section 14.03 Trustee and Collateral Agent Protected 90 Section 14.04 Effect of Execution of Supplemental Indenture 91 Section 14.05 Notation on or Exchange of Notes 91 ARTICLE XV MISCELLANEOUS PROVISIONS Section 15.01 Certificates and Opinions as to Conditions Precedent 91 Section 15.02 [Reserved] 92 Section 15.03 Notices to the Company, Trustee and Collateral Agent 92 Section 15.04 Notices to Holders; Waiver 92 Section 15.05 Legal Holiday 93 Section 15.06 Effects of Headings and Table of Contents 93 Section 15.07 Successors and Assigns 93 Section 15.08 Severability 93 Section 15.09 Benefits of Indenture 93 Section 15.10 Counterparts 93 Section 15.11 Governing Law; Waiver of Trial by Jury 93 Section 15.12 Submission to Jurisdiction 94 Section 15.13 U.S.A. PATRIOT Act 94 Section 15.14 Force Majeure 94 Section 15.15 No Adverse Interpretation of Other Agreements 94 Section 15.16 First Priority/Second Priority Intercreditor and Subordination Agreement 94 EXHIBITS Exhibit A Form of Note Exhibit B Form of Pledge Agreement Additional Pari Passu Joinder Exhibit C Form of Security Agreement Additional Pari Passu Joinder INDENTURE, dated as of March 15, 2019, (as supplemented or amended from time to time, this “Indenture”) by and among Frontier Communications Corporation, a Delaware corporation (the “Company”), the Guarantors party hereto and The Bank of New York Mellon, as trustee (the “Trustee”) and JPMorgan Chase Bank, N.A., as Collateral Agent (as defined below).
